Education
About Us
Working with TipRanks
Follow Us
Sara Kenkare-Mitra Insider Profile
4 Followers
Sara Kenkare-Mitra, President and Head of R&D at Alector, holds 566.98K shares in Alector (Ticker: ALEC), holds ― shares in Unicycive Therapeutics (Ticker: UNCY).
Sara Kenkare-Mitra Alector (ALEC)President and Head of R&D
Alector (ALEC)
President and Head of R&D
Ranked #5,197 out of 102,674 Corporate Insiders
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+31.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sara Kenkare-Mitra holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sara Kenkare-Mitra
Sara Kenkare-Mitra's Trading History
Alector
Jul 01, 2025
President and Head of R&D
Uninformative Buy
―
$907.16K
Unicycive Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Sara Kenkare-Mitra's performance on stock
You May Also Like
Sara Kenkare-Mitra insider profile FAQ
What is the percentage of profitable transactions made by Sara Kenkare-Mitra?
The percentage of profitable transactions made by Sara Kenkare-Mitra is 80%.
What is the average return per transaction made by Sara Kenkare-Mitra?
The average return per transaction made by Sara Kenkare-Mitra is 31.80%.
What stocks does Sara Kenkare-Mitra hold?
Sara Kenkare-Mitra holds: ALEC, UNCY stocks.
What was Sara Kenkare-Mitra’s latest transaction?
Sara Kenkare-Mitra latest transaction was an Uninformative Buy of ―.
What was Sara Kenkare-Mitra's most profitable transaction?
Sara Kenkare-Mitra’s most profitable transaction was an Informative Sell of ALEC stock on March 5, 2024. The return on the trade was 76.90%.
What is Sara Kenkare-Mitra's role in Alector?
Sara Kenkare-Mitra's role in Alector is President and Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.